|
APEX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.349900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.398800E-01 |
| Normal-vs-Stage2 |
8.379600E-01 |
| Normal-vs-Stage3 |
6.809600E-02 |
| Normal-vs-Stage4 |
3.262400E-01 |
| Stage1-vs-Stage2 |
4.805400E-01 |
| Stage1-vs-Stage3 |
1.287570E-01 |
| Stage1-vs-Stage4 |
3.049400E-01 |
| Stage2-vs-Stage3 |
1.068000E-01 |
| Stage2-vs-Stage4 |
3.050000E-01 |
| Stage3-vs-Stage4 |
9.766200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.232630E-01 |
| Normal-vs-AfricanAmerican |
2.245000E-01 |
| Normal-vs-Asian |
5.149200E-01 |
| Caucasian-vs-AfricanAmerican |
9.267600E-01 |
| Caucasian-vs-Asian |
6.289600E-01 |
| AfricanAmerican-vs-Asian |
5.608800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.203800E-01 |
| Normal-vs-Female |
4.210000E-02 |
| Male-vs-Female |
1.717600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.668000E-01 |
| Normal-vs-Extreme_Weight |
5.255800E-01 |
| Normal-vs-Obese |
3.707500E-02 |
| Normal-vs-Extreme_Obese |
5.595400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.335200E-01 |
| Normal_Weight-vs-Obese |
5.363200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.755600E-01 |
| Extreme_Weight-vs-Obese |
1.440400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.862800E-01 |
| Obese-vs-Extreme_Obese |
1.171820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.028990E-01 |
| Normal-vs-Age(41-60Yrs) |
1.585950E-02 |
| Normal-vs-Age(61-80Yrs) |
6.503200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.692600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.283240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.694100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.418300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.522500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.052800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.996300E-02 |
| Normal-VS-Type2 PRCC |
3.739400E-01 |
| Normal-VS-KIRP CIMP |
5.615400E-01 |
| Normal-VS-Unclassified PRCC |
4.274200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.833600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.767810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.082600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.090600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.871000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.536200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.973200E-01 |
| Normal-vs-N1 |
3.180400E-02 |
| Normal-vs-N2 |
1.100210E-03 |
| N0-vs-N1 |
2.961600E-02 |
| N0-vs-N2 |
2.00809999999496E-05 |
| N1-vs-N2 |
3.95639999994923E-06 |
|
|
